
TY  - JOUR
TI  - ASBMR 27th Annual Meeting 1001–1228
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 20
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650201302
DO  - doi:10.1002/jbmr.5650201302
SP  - S2
EP  - S58
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts—Poster
JO  - Alcoholism: Clinical and Experimental Research
VL  - 34
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2010.01210.x
DO  - doi:10.1111/j.1530-0277.2010.01210.x
SP  - 11A
EP  - 243A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral Presentations: Dietary interventions including probiotics, prebiotics and synbiotics
JO  - Neurogastroenterology & Motility
JA  - Neurogastroenterol Motil
VL  - 29
IS  - S2
SN  - 1350-1925
UR  - https://doi.org/10.1111/nmo.13180
DO  - doi:10.1111/nmo.13180
SP  - 3
EP  - 140
PY  - 2017
ER  - 

TY  - JOUR
TI  - Session 1: Genetics
JO  - Cephalalgia
VL  - 20
IS  - 4
SN  - 0333-1024
UR  - https://doi.org/10.1046/j.1468-2982.2000.00204.x
DO  - doi:10.1046/j.1468-2982.2000.00204.x
SP  - 265
EP  - 435
PY  - 2000
ER  - 

TY  - JOUR
TI  - Free Communications
JO  - International Journal of Andrology
VL  - 28
IS  - s1
SN  - 0105-6263
UR  - https://doi.org/10.1111/j.1365-2605.2005.00551_4.x
DO  - doi:10.1111/j.1365-2605.2005.00551_4.x
SP  - 25
EP  - 44
PY  - 2005
ER  - 

TY  - JOUR
AU  - Peters, Edgar J.
C8  - DMRR-15-PER-226.R1
TI  - Pitfalls in diagnosing diabetic foot infections
JO  - Diabetes/Metabolism Research and Reviews
JA  - Diabetes Metab Res Rev
VL  - 32
IS  - S1
SN  - 1520-7552
UR  - https://doi.org/10.1002/dmrr.2736
DO  - doi:10.1002/dmrr.2736
SP  - 254
EP  - 260
KW  - diabetes mellitus
KW  - infection
KW  - foot
KW  - diagnosis
KW  - radiology
KW  - microbiology
PY  - 2016
AB  - Abstract Although the diagnosis of a diabetic foot infection is made based on clinical symptoms and signs, we also use blood laboratory, microbiological and radiological studies to make treatment decisions. All of these diagnostic studies have pitfalls that can lead to a delay in diagnosis. Such delays will likely lead to further tissue damage and to a higher chance of amputation. One of these pitfalls is that some clinicians rely on microbiological, rather than clinical data, to diagnose infection. Though subjective by nature, clinical signs predict outcome of foot infections accurately. Another pitfall is that microbiological data can be misleading. All wounds harbour microorganisms; therefore, a positive wound culture does not mean that a wound is infected. Furthermore, the outcome of cultures of wound swabs does not correlate well with culture results of tissue biopsies. Therapy guidance by wound swab will likely lead to overtreatment of non-pathogenic organisms. Genotyping might have a role in identifying previously unrecognized (combinations of) pathogens in diabetic foot infection, bacteria in sessile phenotype and non-culturable pathogens, e.g. in cases where antibiotics have already been administered. One more pitfall is that the diagnosis of osteomyelitis remains difficult. Although the result of percutaneous bone biopsy is the reference standard for osteomyelitis, some other diagnostic modalities can aid in the diagnosis. A combination of several of these diagnostic tests is probably a good strategy to achieve a higher diagnostic accuracy. Relying on a single test will likely lead to misidentification of patients with osteomyelitis with associated overtreatment and undertreatment. Copyright ? 2016 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Abstracts of the 7th BOMSS Annual Scientific Meeting, 28 – 29 January 2016, City Hall, Cardiff
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 103
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.10133
DO  - doi:10.1002/bjs.10133
SP  - 1
EP  - 25
PY  - 2016
ER  - 

TY  - JOUR
AU  - Hamizan, Aneeza W.
AU  - Christensen, Jenna M.
AU  - Ebenzer, Jareen
AU  - Oakley, Gretchen
AU  - Tattersall, Jessica
AU  - Sacks, Raymond
AU  - Harvey, Richard J.
TI  - Middle turbinate edema as a diagnostic marker of inhalant allergy
JO  - International Forum of Allergy & Rhinology
JA  - Int Forum Allergy Rhinol.
VL  - 7
IS  - 1
SN  - 2042-6976
UR  - https://doi.org/10.1002/alr.21835
DO  - doi:10.1002/alr.21835
SP  - 37
EP  - 42
KW  - allergic
KW  - atopy
KW  - endoscopy
KW  - middle turbinate
KW  - nasal polyp
KW  - rhinitis
KW  - turbinates
PY  - 2017
AB  - Background Middle turbinate edema could be a characteristic feature of aeroallergen sensitization. In this study we sought to determine the diagnostic characteristics of middle turbinate edema as a marker of inhalant allergy. Methods A cross-sectional diagnostic study was performed on patients who had undergone nasal endoscopy and allergy testing. Allergy status was determined by positive serology or epicutaneous testing. Endoscopy was reviewed by blinded assessors for middle turbinate head edema. Appearance was graded as either normal, focal, multifocal, diffuse, or polypoid edema. Receiver-operator (ROC) analysis, likelihood ratio (LR), sensitivity, specificity, and positive predictive value (PPV) were determined. Results One hundred eighty-seven patients representing 304 nasal cavities were assessed (42% female, age 39.74 ± 14.7 years, 57% allergic). Diffuse edema (PPV 91.7%/LR = 8) and polypoid edema (PPV 88.9%/LR = 6.2) demonstrated the strongest association with inhalant allergy. Multifocal edema was used as a cut-off to represent inhalant allergy from ROC analysis, which demonstrated 94.7% specificity and 23.4% sensitivity. The PPV for multifocal was 85.1% and LR = 4.4. Conclusion Middle turbinate edema is a useful nasal endoscopic feature to predict presence of inhalant allergy and, although not sensitive, has excellent PPV.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Tropical Medicine & International Health
JA  - Trop Med Int Health
VL  - 20
IS  - S1
SN  - 1360-2276
UR  - https://doi.org/10.1111/tmi.12574
DO  - doi:10.1111/tmi.12574
SP  - 171
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts of the North American Veterinary Dermatology Forum 15–18 April 2015 Nashville, TN, USA
JO  - Veterinary Dermatology
JA  - Vet Dermatol
VL  - 26
IS  - 3
SN  - 0959-4493
UR  - https://doi.org/10.1111/vde.12213
DO  - doi:10.1111/vde.12213
SP  - 133
EP  - 159
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00029.x
DO  - doi:10.1111/j.1538-7836.2007.tb00029.x
SP  - P-T-401
EP  - P-T-700
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 113
IS  - s3
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.12627
DO  - doi:10.1111/bju.12627
SP  - 1
EP  - 37
PY  - 2014
ER  - 

TY  - JOUR
TI  - Free Papers
JO  - Developmental Medicine & Child Neurology
JA  - Dev Med Child Neurol
VL  - 55
IS  - s3
SN  - 0012-1622
UR  - https://doi.org/10.1111/dmcn.12247
DO  - doi:10.1111/dmcn.12247
SP  - 2
EP  - 49
PY  - 2013
ER  - 

TY  - JOUR
TI  - Oral Abstract Session OAS
JO  - Allergy
JA  - Allergy
VL  - 71
IS  - S102
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12970
DO  - doi:10.1111/all.12970
SP  - 3
EP  - 94
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts of the BAUS Annual Meeting: Harrogate, UK, 21-25 June, 2004
JO  - BJU International
VL  - 93
IS  - s4
SN  - 1464-4096
UR  - https://doi.org/10.1111/j.1464-410X.2004.04853.x
DO  - doi:10.1111/j.1464-410X.2004.04853.x
SP  - 1
EP  - 116
PY  - 2004
ER  - 

TY  - JOUR
AU  - Palladino, Michael
AU  - Thomson, Lynda
AU  - Swift,, Brian
AU  - Merli, Geno J.
TI  - Implementing the new oral anticoagulants into the hospital formulary
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 87
IS  - S1
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.23208
DO  - doi:10.1002/ajh.23208
SP  - S127
EP  - S132
PY  - 2012
AB  - Abstract The new oral anticoagulants may prove to be one of most significant innovations in clinical practice in the past 60 years. Apixaban and rivaroxaban are direct inhibitors of Factor Xa, while dabigatran inhibits Factor IIa. The predictable pharmacological profile of these new agents allows physicians to prescribe these drugs without the need for routine coagulation monitoring, which is the mainstay of warfarin therapy. In addition, these new agents have not been shown to have any food interactions and minimal drug?drug interactions, interactions are limited to the p-glycoprotein (p-Gp) transporter or cytochrome P450 (CYP450) system, each drug is unique in its drug interaction profile, as will be discussed below. These unique pharmacokinetics profiles may usher in for clinicians a new era of managing thromboembolic disorders. In this article, the pharmacology of these new oral anticoagulants will be reviewed along with the major clinical trials evaluating the use of these agents for thromboembolic prophylaxis in patients undergoing total hip and knee arthroplastic surgery, the treatment of venous thromboembolic disorders and stroke prevention in atrial fibrillation. Am. J. Hematol., 2012. ? 2012 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - 2016 ASPHO ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 63
IS  - S1
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25998
DO  - doi:10.1002/pbc.25998
SP  - S7
EP  - S103
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts 1 to 257
JO  - Hepatology
JA  - Hepatology
VL  - 42
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.20923
DO  - doi:10.1002/hep.20923
SP  - 196A
EP  - 298A
PY  - 2005
ER  - 

TY  - JOUR
TI  - Plenary Lectures: Oral Sessions
JO  - Pharmacology & Toxicology
VL  - 89
IS  - S1
SN  - 0901-9928
UR  - https://doi.org/10.1111/j.0901-9928.2001.tb00001.x
DO  - doi:10.1111/j.0901-9928.2001.tb00001.x
SP  - 7
EP  - 36
PY  - 2001
ER  - 

TY  - JOUR
TI  - ASBMR 18th annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 11
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650111302
DO  - doi:10.1002/jbmr.5650111302
SP  - S1
EP  - S500
PY  - 1996
ER  - 
